3rd Quarter - Report — INLET STRATEGIES for COHERUS BIOSCIENCES, INC (2026)

Firm

INLET STRATEGIES

Client

COHERUS BIOSCIENCES, INC

Income

$60,000

Expenses

—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to domestic manufacturing of pharmaceuticals Federal financial support for the American Biotech Industry Issues related to the procurement of the medicine Udenyca

Lobbyist	Covered position, as disclosed
KENDRA WHARTON New	Associate Deputy Attorney General, United States Department of Justice. January 2025 - July 2005: Legislative Aide, Senator Mitch McConnell. May 2008 - November 2012
THOMAS WHARTON	Legislative Assistant, Senator Lieberman. May 2011-June 2012 Senior Legislative Assistant, Representative Dan Boren July 2008-June 2011

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); White House Office; Office of Management & Budget (OMB)

Medicare/Medicaid MMM

Federal Financial Support for the American Biotech Industry Issues related to the procurement of the medicine Udenyca

Lobbyist	Covered position, as disclosed
KENDRA WHARTON New	Associate Deputy Attorney General. United States Department of Justice. January 2025 - July 2025: Legislative Aide, Senator Mitch McConnell. May 2008 - November 2012.
THOMAS WHARTON	Legislative Assistant. Senator Lieberman May 2011-June 2012 Senior Legislative Assistant. Representative Dan Boren. July 2008-June 2011

Contacted: Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; SENATE; Commerce, Dept of (DOC); White House Office

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.